ANSWERS TO CONTINUING MEDICAL E DUCATION QUESTIONS

Carlo Tascini(Ospedale D. Cotugno), F. Menichetti(University of Perugia), Simone Ferranti(Azienda Ospedaliera Universitaria Pisana), Fernando Messina(Hospital Muñiz), G Gemignani(Azienda Ospedaliera Universitaria Pisana)

Unknown

January 1, 2002

Cited by 0

Related Papers

Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>

|Clinical Infectious Diseases|2018|351

Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study

|Clinical Infectious Diseases|2021|264

Added Value of <sup>99m</sup>Tc-HMPAO–Labeled Leukocyte SPECT/CT in the Characterization and Management of Patients with Infectious Endocarditis

|Journal of Nuclear Medicine|2012|221

Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG

|Critical Care|2023|65

Infective endocarditis: Echocardiographic imaging and new imaging modalities

|Journal of Cardiovascular Echography|2019|58